Incidence of Pneumocystis Jirovecii Infection and Duration of Prophylaxis After Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Mishra, Asmita [1 ]
Chavez, Julio C. [1 ]
Tomblyn, Marcie [1 ]
Anasetti, Claudio [1 ]
Ayala, Ernesto [1 ]
Field, Teresa [1 ]
Kharfan-Dabaja, Mohamed [1 ]
Perez, Lia Elena [1 ]
Fernandez, Hugo [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.366
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
312
引用
收藏
页码：S267 / S268
页数：2
相关论文
共 50 条
  • [21] Risk factors associated with Pneumocysctis jirovecii pneumonia after allogeneic stem cell transplantation; when can PCP prophylaxis be discontinued?
    Tsuji, M.
    Araoka, H.
    Asano-Mori, Y.
    Uchida, N.
    Yuasa, M.
    Koji, D.
    Kageyama, K.
    Wada, S.
    Nishida, A.
    Ishiwata, K.
    Takagi, S.
    Yamamoto, H.
    Yamamoto, G.
    Izutsu, K.
    Wake, A.
    Makino, S.
    Yoneyama, A.
    Taniguchi, S.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S406 - S406
  • [22] Pneumocystis jirovecii pneumonia in patientswith hematological diseases after hematopoietic stem cell transplantation and chemotherapy
    Rogacheva, Y. A.
    Popova, M. O.
    Volkova, A. G.
    Ekushev, K. A.
    Pirogova, O. V.
    Pinegina, O. N.
    Ignatieva, S. M.
    Bogomolova, T. S.
    Paina, O. V.
    Bykova, T. A.
    Darskaya, E. I.
    Vladovskaya, M. D.
    Smirnov, B. I.
    Moiseev, I. S.
    Bondarenko, S. N.
    Zubarovskaya, L. S.
    Klimko, N. N.
    Afanasyev, B. V.
    MEDICAL MYCOLOGY, 2018, 56 : S69 - S69
  • [23] Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation
    Diri, R.
    Anwer, F.
    Yeager, A.
    Krishnadasan, R.
    McBride, A.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (01) : 63 - 69
  • [24] Pneumomediastinum Case Secondary to Pneumocystis Jirovecii Infection as Late Complication in an Allogeneic Hematopoietic Stem Cell Tranplant Patient
    Akyol, G.
    Turak, E. Ermis
    Yildizhan, E.
    Demir, K.
    Cetin, M.
    Kaynar, L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S566 - S567
  • [25] Foscarnet -: an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?
    Ordemann, R
    Naumann, R
    Geissler, G
    Kroschinsky, F
    Bornhäuser, M
    Schwerdtfeger, R
    Ehninger, G
    ANNALS OF HEMATOLOGY, 2000, 79 (08) : 432 - 436
  • [26] Foscarnet – an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?
    R. Ordemann
    R. Naumann
    G. Geißler
    F. Kroschinsky
    M. Bornhäuser
    R. Schwerdtfeger
    G. Ehninger
    Annals of Hematology, 2000, 79 : 432 - 436
  • [27] Pneumocystis jirovecii Infection in autologous hematopoietic stem cell transplant recipients
    John Coda
    Kadee Raser
    Sarah M. Anand
    Monalisa Ghosh
    Kevin Gregg
    Jinju Li
    John J. Maciejewski
    Attaphol Pawarode
    Mary M. Riwes
    Christina Tillman
    Avery Polk
    Malathi Kandarpa
    Moshe Talpaz
    Sung Won Choi
    Gregory A. Yanik
    John M. Magenau
    Matthew J. Pianko
    Bone Marrow Transplantation, 2023, 58 : 446 - 451
  • [28] Kinetics of IgG subclasses and their effects on the incidence of infection after allogeneic hematopoietic stem cell transplantation
    Koh, Shiro
    Koh, Hideo
    Nanno, Satoru
    Okamura, Hiroshi
    Nakashima, Yasuhiro
    Nakamae, Mika
    Hirose, Asao
    Hino, Masayuki
    Nakamae, Hirohisa
    TRANSPLANT IMMUNOLOGY, 2021, 67
  • [29] Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation
    Mousset, S.
    Bug, G.
    Heinz, W. J.
    Tintelnot, K.
    Rickerts, V.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 261 - 264
  • [30] Extension of CMV prophylaxis possible after allogeneic stem cell transplantation
    Freyer, Martina
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 (04) : 162 - 162
12345